Refining Therapeutic Approaches in R/R MM: Expert Guidance on Bispecific Antibody Therapy Optimization

Gain knowledge and insights on bispecific antibody therapy optimization in R/R MM through an expert commentary, on-demand webcast, podcasts, interactive decision support tool, and downloadable slides.

Share

Program Content

Activities

BsAbs in MM
A Quick Guide to Bispecific Antibodies for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 24, 2024

Expires: September 23, 2025

Faculty

cover img faculity

Caitlin Costello, MD

Clinical Professor of Medicine
Director, Multiple Myeloma Program
Moores Cancer Center
University of California, San Diego
La Jolla, California

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC.

Supporters

Supported by educational grants from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC, Pfizer Inc. and Regeneron Pharmaceuticals, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc

Partners

Clinical Care Options, LLC

ProCE Banner